What is The Normal Co-codamol 30/500mg Dose?
Co-codamol 30/500mg is a medication commonly prescribed for pain relief, containing two active ingredients: codeine phosphate (30mg) and paracetamol (500mg). This... Read more.
PRISM BioLab and Lilly Enter into a Drug Discovery Collaboration on a Protein-Protein Interaction Target
PRISM BioLab, Co. Ltd. (“PRISM”), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction... Read more.
Does the Second Dose of Misoprostol Hurt?
Misoprostol is a medication commonly used for various medical purposes, including inducing labor, preventing stomach ulcers, and, in combination with other medications,... Read more.
Does the Second Dose of Sutab Work Faster?
Sutab is a medication commonly prescribed for bowel preparation before diagnostic procedures like colonoscopies. The effectiveness and efficiency of this medication... Read more.
FDA warns of rare but serious drug reaction to the antiseizure medicines levetiracetam (Keppra, Keppra XR, Elepsia XR, Spritam) and clobazam (Onfi, Sympazan)
AUDIENCE: Patient, Health Professional, Neurology, Dermatology, Allergy and Immunology, Pharmacy ISSUE: The FDA is warning that the antiseizure medicines, Keppra,... Read more.
Are There Eye Drops That Change Eye Color?
The idea of changing eye color with the use of eye drops has captured the imagination of many individuals seeking a non-invasive way to alter their appearance. While... Read more.
Diet Pill Horror Story
Like the story of the 25-year-old father in the video above, Sarah’s journey with diet pills began with a simple desire to shed a few pounds before an important... Read more.
Can Nootropic Pills Make You Smarter?
In a world where cognitive performance is highly valued, the quest for ways to enhance intelligence and boost mental acuity has led to the rise of nootropic pills.... Read more.
Ozempic Vs. Mounjaro: New Study Confirms Why Mounjaro is Better Than Ozempic For Weight Loss
The groundbreaking preprint study conducted by Truveta, a prominent healthcare data company, sheds light on the comparative effectiveness of Eli Lilly’s Mounjaro... Read more.
FDA Approves First Therapy for Rare Type of Non-Cancerous Tumors
Today, the U.S. Food and Drug Administration approved Ogsiveo (nirogacestat) tablets for adult patients with progressing desmoid tumors who require systemic treatment.... Read more.